BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 21258248)

  • 1. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma contains more immune tolerance regulatory t-cell lymphocytes (versus squamous carcinoma) in non-small-cell lung cancer.
    Black CC; Turk MJ; Dragnev K; Rigas JR
    Lung; 2013 Jun; 191(3):265-70. PubMed ID: 23494387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
    Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
    J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
    Su YJ; Ren K; Li H; Ren XB; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
    Wang HY; Shi QF; Sun Y; He JJ; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):95-100. PubMed ID: 23710915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FOXP3 expression with non-small cell lung cancer.
    Dimitrakopoulos FI; Papadaki H; Antonacopoulou AG; Kottorou A; Gotsis AD; Scopa C; Kalofonos HP; Mouzaki A
    Anticancer Res; 2011 May; 31(5):1677-83. PubMed ID: 21617226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
    Gai XD; Song Y; Li C; Lei YM; Yang B
    Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
    Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of CCR6, CCR7 and CD4(+)CD25(+) Foxp3(+) regulatory T cells in laryngeal squamous cell carcinoma and neck lymphatic metastasis].
    Chen B; Lu LM; Tao L; Zhou L; Li SM; Zhu L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Sep; 45(9):759-64. PubMed ID: 21092675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
    Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
    Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
    Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
    J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T-cells and micrometastasis in lymph nodes of stage I NSCLC.
    Hanagiri T; Fukumoto M; Koyanagi Y; Furutani Y; Tanaka F
    Anticancer Res; 2014 Dec; 34(12):7185-90. PubMed ID: 25503147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape.
    Fu HY; Li C; Yang W; Gai XD; Jia T; Lei YM; Li Y
    Acta Histochem; 2013 Mar; 115(2):151-7. PubMed ID: 22749378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer.
    Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H
    Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.